81771-20-2 (7H-[1,3]二氧杂环[5',4'':2',3']环氧并[4',4'a][1]苯并吡喃[5',6':6,7]茚并[1,2-b]异苯并呋喃[5,6-e]吲哚-13(8H)-酮,3-(3,3-二甲基环氧乙烷基)-1,4a,4b,5b,6,7a,9,9a,10,12,12a,16,16b,16c,17,18,18a,19a-十八氢-5b-羟基-1,1,10,10,12,12,16b,16c-八甲基-(3S,4aR,4bR,5aS,5bS,7aS,9aR,12aR,16bS,16cR,18aS,19aS)-(9CI),7H-[1,3]Dioxino[5'',4'':2',3']oxireno[4',4'a][1]benzopyrano[5',6':6,7]indeno[1,2-b]isobenzofuro[5,6-e]indol-13(8H)-one,3-(3,3-dimethyloxiranyl)-1,4a,4b,5b,6,7a,9,9a,10,12,12a,16,16b,16c,17,18,18a,19a-octadecahydro-5b-hydroxy-1,1,10,10,12,12,16b,16c-octamethyl-,(3S,4aR,4bR,5aS,5bS,7aS,9aR,12aR,16bS,16cR,18aS,19aS)- (9CI))

CAS号:
81771-20-2
中文名称:
7H-[1,3]二氧杂环[5',4'':2',3']环氧并[4',4'a][1]苯并吡喃[5',6':6,7]茚并[1,2-b]异苯并呋喃[5,6-e]吲哚-13(8H)-酮,3-(3,3-二甲基环氧乙烷基)-1,4a,4b,5b,6,7a,9,9a,10,12,12a,16,16b,16c,17,18,18a,19a-十八氢-5b-羟基-1,1,10,10,12,12,16b,16c-八甲基-(3S,4aR,4bR,5aS,5bS,7aS,9aR,12aR,16bS,16cR,18aS,19aS)-(9CI)
英文名称:
7H-[1,3]Dioxino[5'',4'':2',3']oxireno[4',4'a][1]benzopyrano[5',6':6,7]indeno[1,2-b]isobenzofuro[5,6-e]indol-13(8H)-one,3-(3,3-dimethyloxiranyl)-1,4a,4b,5b,6,7a,9,9a,10,12,12a,16,16b,16c,17,18,18a,19a-octadecahydro-5b-hydroxy-1,1,10,10,12,12,16b,16c-octamethyl-,(3S,4aR,4bR,5aS,5bS,7aS,9aR,12aR,16bS,16cR,18aS,19aS)- (9CI)
分子式:
C42H55NO8
分子量:
701.888013124466

7H-[1,3]二氧杂环[5',4'':2',3']环氧并[4',4'a][1]苯并吡喃[5',6':6,7]茚并[1,2-b]异苯并呋喃[5,6-e]吲哚-13(8H)-酮,3-(3,3-二甲基环氧乙烷基)-1,4a,4b,5b,6,7a,9,9a,10,12,12a,16,16b,16c,17,18,18a,19a-十八氢-5b-羟基-1,1,10,10,12,12,16b,16c-八甲基-(3S,4aR,4bR,5aS,5bS,7aS,9aR,12aR,16bS,16cR,18aS,19aS)-(9CI)(81771-20-2)名称与标识符

名称

英文别名:
7H-[1,3]Dioxino[5'',4'':2',3']oxireno[4',4'a][1]benzopyrano[5',6':6,7]indeno[1,2-b]isobenzofuro[5,6-e]indol-13(8H)-one,3-(3,3-dimethyloxiranyl)-1,4a,4b,5b,6,7a,9,9a,10,12,12a,16,16b,16c,17,18,18a,19a-octadecahydro-5b-hydroxy-1,1,10,10,12,12,16b,16c-octamethyl-,(3S,4aR,4bR,5aS,5bS,7aS,9aR,12aR,16bS,16cR,18aS,19aS)- (9CI);7H-[1,3]Dioxino[5'',4'':2',3']oxireno[4',4'a][1]benzopyrano[5',6':6,7]indeno[1,2-b]isobenzofuro[5,6-e]indol-13(8H)-one,3-(3,3;lolitrem A;CHEBI:203758;81771-20-2;NRO91W1R44;(1S,9R,13R,19S,22S,23S,25R,26R,28S,31S,33S,36R)-28-(3,3-dimethyloxiran-2-yl)-22-hydroxy-1,10,10,12,12,30,30,36-octamethyl-11,24,27,29,32-pentaoxa-3-azadecacyclo[17.17.0.02,17.04,16.07,15.09,13.022,36.023,25.023,33.026,31]hexatriaconta-2(17),4(16),5,7(15)-tetraen-8-one;UNII-NRO91W1R44;

标识符

InChIKey:
PXJKIAMLVLKXQP-GTHCCFMRSA-N
Inchi:
1S/C42H55NO8/c1-35(2)23-18-21-20(28(44)27(23)36(3,4)51-35)11-12-24-26(21)22-17-19-13-16-41(45)39(9,40(19,10)30(22)43-24)15-14-25-42(41)32(49-42)29-31(46-25)37(5,6)50-34(47-29)33-38(7,8)48-33/h11-12,19,23,25,27,29,31-34,43,45H,13-18H2,1-10H3/t19-,23+,25-,27-,29+,31-,32+,33?,34-,39+,40+,41-,42-/m0/s1
SMILES:
O1[C@@H]2[C@H]3[C@@H](C(C)(C)O[C@@H](C4C(C)(C)O4)O3)O[C@H]3CC[C@]4(C)[C@@]5(C)C6=C(C7C8=C(C([C@H]9C(C)(C)OC(C)(C)[C@@H]9C8)=O)C=CC=7N6)C[C@@H]5CC[C@]4([C@@]123)O

7H-[1,3]二氧杂环[5',4'':2',3']环氧并[4',4'a][1]苯并吡喃[5',6':6,7]茚并[1,2-b]异苯并呋喃[5,6-e]吲哚-13(8H)-酮,3-(3,3-二甲基环氧乙烷基)-1,4a,4b,5b,6,7a,9,9a,10,12,12a,16,16b,16c,17,18,18a,19a-十八氢-5b-羟基-1,1,10,10,12,12,16b,16c-八甲基-(3S,4aR,4bR,5aS,5bS,7aS,9aR,12aR,16bS,16cR,18aS,19aS)-(9CI)(81771-20-2)物化性质

实验特性

  • 颜色与性状 : Solid powder

计算特性

  • 精确分子量 : 701.39276771g/mol
  • 氢键供体数量 : 2
  • 氢键受体数量 : 8
  • 可旋转化学键数量 : 1
  • 同位素质量 : 701.39276771g/mol
  • 重原子数量 : 51
  • 复杂度 : 1580
  • 同位素原子数量 : 0
  • 确定原子立构中心数量 : 12
  • 不确定原子立构中心数量 : 1
  • 确定化学键立构中心数量 : 0
  • 不确定化学键立构中心数量 : 0
  • 共价键单元数量 : 1
  • 疏水参数计算参考值(XlogP) : 4.7
  • 拓扑分子极性表面积 : 115Ų

7H-[1,3]二氧杂环[5',4'':2',3']环氧并[4',4'a][1]苯并吡喃[5',6':6,7]茚并[1,2-b]异苯并呋喃[5,6-e]吲哚-13(8H)-酮,3-(3,3-二甲基环氧乙烷基)-1,4a,4b,5b,6,7a,9,9a,10,12,12a,16,16b,16c,17,18,18a,19a-十八氢-5b-羟基-1,1,10,10,12,12,16b,16c-八甲基-(3S,4aR,4bR,5aS,5bS,7aS,9aR,12aR,16bS,16cR,18aS,19aS)-(9CI)(81771-20-2)安全信息

7H-[1,3]二氧杂环[5',4'':2',3']环氧并[4',4'a][1]苯并吡喃[5',6':6,7]茚并[1,2-b]异苯并呋喃[5,6-e]吲哚-13(8H)-酮,3-(3,3-二甲基环氧乙烷基)-1,4a,4b,5b,6,7a,9,9a,10,12,12a,16,16b,16c,17,18,18a,19a-十八氢-5b-羟基-1,1,10,10,12,12,16b,16c-八甲基-(3S,4aR,4bR,5aS,5bS,7aS,9aR,12aR,16bS,16cR,18aS,19aS)-(9CI)(81771-20-2)参考资料

Reaxys RN:
PubChem CID: